Article | August 29, 2022

Debunking Common Myths About Clinical Trials

By Craig Morgan

GettyImages-1302453801 trial design ps

For much of the public, drug development is shrouded in mystery.

When it comes to clinical trials in particular, myths are common. From the view that clinical trials are dangerous, to the idea that participants don’t know the details of a trial or the treatments they might take, false notions persist.

For an industry so openly regulated, monitored, and reviewed, it’s ironic that public perception of clinical trials is often disconnected from reality.

Yet inaccurate perceptions about clinical trials have the real potential to inhibit participation and the development of new drugs.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader